M.p. Eric Chan is CAO at CASTLIGHT HEALTH, INC. (CSLT). They have made 15 open-market trades across 1 company since 2018, most recently 2022-02-17.
CIK 0001717376
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 15 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CSLT | 126,058 | $258K |
Shares reported on the most recent Form 4, priced at the 2021-11-18 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CSLT | SELL | 2021-11-17 | 2021-11-18 | $1.78 | $14K | -15.9% | -12.5% | +16.5% |
| CSLT | SELL | 2021-08-17 | 2021-08-17 | $1.71 | $13K | +5.2% | -0.6% | +6.4% |
| CSLT | SELL | 2021-05-17 | 2021-05-18 | $1.61 | $16K | -0.5% | +20.2% | +1.1% |
| CSLT | SELL | 2021-02-17 | 2021-02-18 | $1.89 | $16K | +15.5% | +2.9% | +0.0% |
| CSLT | SELL | 2020-11-17 | 2020-11-18 | $1.14 | $8K | -1.7% | +1.7% | +68.1% |
| CSLT | SELL | 2020-08-17 | 2020-08-18 | $1.17 | $8K | +11.6% | -8.3% | -2.5% |
| CSLT | SELL | 2020-05-18 | 2020-05-19 | $0.76 | $4K | +7.0% | +12.3% | +63.4% |
| CSLT | SELL | 2020-02-18 | 2020-02-19 | $1.25 | $4K | -25.3% | -41.3% | -46.0% |
| CSLT | SELL | 2019-11-18 | 2019-11-19 | $1.34 | $8K | -3.6% | -5.1% | -9.4% |
| CSLT | SELL | 2019-08-19 | 2019-08-20 | $1.40 | $8K | -6.0% | +6.0% | -8.7% |
| CSLT | SELL | 2019-05-17 | 2019-05-20 | $3.51 | $10K | -5.5% | -10.4% | -57.8% |
| CSLT | SELL | 2019-02-20 | 2019-02-20 | $3.17 | $17K | +26.9% | +22.1% | +7.7% |
| CSLT | SELL | 2018-11-19 | 2018-11-20 | $2.64 | $20K | +0.0% | -28.4% | +16.7% |
| CSLT | SELL | 2018-08-17 | 2018-08-20 | $2.85 | $2K | +0.0% | -5.0% | -9.0% |
| CSLT | SELL | 2018-05-17 | 2018-05-17 | $3.80 | $2K | -2.6% | +1.3% | -24.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.